Retour

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024

Calendar Calendar of Events

RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024. Management will host a conference call and webcast that day to discuss the Company’s financial and business results.

GlobeNewswire Inc. • 08/05/2024 à 00:15:00
Fennec Pharmaceuticals Inc. Common Stock
Address: PO BOX 13628
Postal Code: 27709
City: RESEARCH TRIANGLE PARK
State: NC
Phone Number: (919) 636-4530
Website: https://www.fennecpharma.com
Status: Active
Company Info

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

List Date2002-01-28
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001211583
Composite figiBBG000DTH814
Share Class figiBBG001S69M23
Market Cap192,347,873 USD
SIC Code2836
SIC DescriptionBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Total Employees29
Share Class Shares Outstanding27320000
Weighted Shares Outstanding27322141
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
6.851
6.965
6.995
7.41
10.025
Variance
-1.64%
-0.88%
-6.92%
-26.08%
2.61%
Open
6.965
7.027
7.515
10.025
9.77
Highest
7.07
7.205
8.375
10.1
10.065
Lowest
7.06
7.205
8.375
10.1
10.065
History
PeriodVarhighestlowest
1 week
-29.88%
10.065
7.06
1 month
-26.65%
9.499
7.06
3 month
-28.8%
10.419
7.06
6 month
-16.96%
8.8
7.06
1 year
-6.92%
7.54
6.3
3 year
2.95%
6.72
3.8219
5 year
70.85%
4.03
3.255
10 year
-32.3%
12.42
3.255
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-12 2023-08-07 2023-11-09 UNPUB
Assets 21,821,000 19,437,000 19,028,000 UNPUB
Current Assets 21,662,000 19,331,000 18,946,000 UNPUB
Current Liabilities 4,020,000 3,778,000 3,913,000 UNPUB
Equity -7,339,000 -9,727,000 -10,531,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent -7,339,000 -9,727,000 -10,531,000 UNPUB
Liabilities 29,160,000 29,164,000 29,559,000 UNPUB
Liabilities And Equity 21,821,000 19,437,000 19,028,000 UNPUB
Noncurrent Assets 159,000 106,000 82,000 UNPUB
Noncurrent Liabilities 25,140,000 25,386,000 25,646,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-12 2023-08-07 2023-11-09 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 UNPUB
Net Cash Flow, Continuing 0 0 0 UNPUB
Net Cash Flow From Financing Activities 193,000 514,000 201,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 193,000 514,000 201,000 UNPUB
Net Cash Flow From Investing Activities 5,384,000 3,432,000 2,559,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 5,384,000 3,432,000 2,559,000 UNPUB
Net Cash Flow From Operating Activities -5,577,000 -3,946,000 -2,760,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -5,577,000 -3,946,000 -2,760,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-12 2023-08-07 2023-11-09 UNPUB
Comprehensive Income/Loss -6,052,000 -5,444,000 -1,867,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -6,052,000 -5,444,000 -1,867,000 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-12 2023-08-07 2023-11-09 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 7,634,000 -7,065,000 0 UNPUB
Cost Of Revenue 95,000 148,000 331,000 UNPUB
Costs And Expenses 6,852,000 -7,843,000 7,532,000 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 1,582,000 3,177,000 6,184,000 UNPUB
Income/Loss From Continuing Operations After Tax -6,052,000 -5,444,000 -1,867,000 UNPUB
Income/Loss From Continuing Operations Before Tax -6,052,000 -5,444,000 6,515,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -6,052,000 -5,444,000 -1,867,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -6,052,000 -5,444,000 -1,867,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -6,052,000 -5,444,000 -1,867,000 UNPUB
Operating Expenses 6,852,000 -7,843,000 7,201,000 UNPUB
Operating Income/Loss -5,270,000 -4,666,000 -1,017,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 1,582,000 -12,509,000 6,515,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-12 2022-11-14 2023-03-29
Assets 19,149,000 15,568,000 30,417,000 26,939,000
Current Assets 19,128,000 15,554,000 30,153,000 26,728,000
Current Liabilities 2,136,000 3,037,000 2,927,000 4,609,000
Equity 12,524,000 8,541,000 2,802,000 -2,569,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 12,524,000 8,541,000 2,802,000 -2,569,000
Liabilities 6,625,000 7,027,000 27,615,000 29,508,000
Liabilities And Equity 19,149,000 15,568,000 30,417,000 26,939,000
Noncurrent Assets 21,000 14,000 264,000 211,000
Noncurrent Liabilities 4,489,000 3,990,000 24,688,000 24,899,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-12 2022-11-14 2023-03-29
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 -3,390,000 0 0
Net Cash Flow, Continuing 0 -3,390,000 0 0
Net Cash Flow From Financing Activities 15,000 46,000 19,847,000 20,732,000
Net Cash Flow From Financing Activities, Continuing 15,000 46,000 19,847,000 20,732,000
Net Cash Flow From Investing Activities 2,841,000 3,344,000 -14,837,000 -2,674,000
Net Cash Flow From Investing Activities, Continuing 2,841,000 3,344,000 -14,837,000 -2,674,000
Net Cash Flow From Operating Activities -2,856,000 -3,390,000 -5,010,000 -18,058,000
Net Cash Flow From Operating Activities, Continuing -2,856,000 -3,390,000 -5,010,000 -18,058,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-12 2022-11-14 2023-03-29
Comprehensive Income/Loss -3,696,000 -5,072,000 -8,089,000 -23,714,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,696,000 -5,072,000 -8,089,000 -23,714,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-12 2022-11-14 2023-03-29
Basic Earnings Per Share 0 0 0 -1
Benefits Costs and Expenses UNPUB UNPUB UNPUB 25,163,000
Cost Of Revenue UNPUB UNPUB UNPUB 86,000
Costs And Expenses UNPUB UNPUB UNPUB 24,038,000
Diluted Earnings Per Share 0 0 0 -1
Gross Profit UNPUB UNPUB UNPUB 1,449,000
Income/Loss From Continuing Operations After Tax -3,696,000 -5,072,000 -8,089,000 -23,714,000
Income/Loss From Continuing Operations Before Tax -3,696,000 -5,072,000 -8,089,000 -23,714,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,696,000 -5,072,000 -8,089,000 -23,714,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,696,000 -5,072,000 -8,089,000 -23,714,000
Net Income/Loss Available To Common Stockholders, Basic -3,696,000 -5,072,000 -8,089,000 -23,714,000
Operating Expenses UNPUB UNPUB UNPUB 24,038,000
Operating Income/Loss -3,546,000 -5,009,000 -7,899,000 -22,589,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues UNPUB UNPUB UNPUB 1,449,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-10 2021-11-10 2022-02-28
Assets 27,825,000 28,115,000 26,014,000 22,414,000
Current Assets 27,825,000 28,074,000 26,014,000 22,387,000
Current Liabilities 2,892,000 848,000 2,014,000 1,654,000
Equity 24,933,000 22,281,000 19,013,000 15,772,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 24,933,000 22,281,000 19,013,000 15,772,000
Liabilities -24,933,000 5,834,000 7,001,000 6,642,000
Liabilities And Equity 27,825,000 28,115,000 26,014,000 22,414,000
Noncurrent Assets 0 41,000 35,000 27,000
Noncurrent Liabilities 0 4,986,000 4,987,000 4,988,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-10 2021-11-10 2022-02-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -3,593,000 0 -2,958,000 0
Net Cash Flow, Continuing -3,593,000 0 -2,958,000 0
Net Cash Flow From Financing Activities 0 4,968,000 0 4,978,000
Net Cash Flow From Financing Activities, Continuing 0 4,968,000 0 4,978,000
Net Cash Flow From Investing Activities 3,593,000 -542,000 2,958,000 9,244,000
Net Cash Flow From Investing Activities, Continuing 3,593,000 -542,000 2,958,000 9,244,000
Net Cash Flow From Operating Activities -3,593,000 -4,426,000 -2,958,000 -14,222,000
Net Cash Flow From Operating Activities, Continuing -3,593,000 -4,426,000 -2,958,000 -14,222,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-10 2021-11-10 2022-02-28
Comprehensive Income/Loss -4,733,000 -4,001,000 -4,185,000 -17,346,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,733,000 -4,001,000 -4,185,000 -17,346,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-10 2021-11-10 2022-02-28
Basic Earnings Per Share 0 0 0 -1
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share 0 0 0 -1
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,733,000 -4,001,000 -4,185,000 -17,346,000
Income/Loss From Continuing Operations Before Tax -4,733,000 -4,001,000 -4,185,000 -17,346,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating 0 9,000 UNPUB UNPUB
Net Income/Loss -4,733,000 -4,001,000 -4,185,000 -17,346,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,733,000 -4,001,000 -4,185,000 -17,346,000
Net Income/Loss Available To Common Stockholders, Basic -4,733,000 -4,001,000 -4,185,000 -17,346,000
Operating Expenses 4,923,000 UNPUB UNPUB 17,223,000
Operating Income/Loss -4,923,000 -3,920,000 -4,173,000 -17,223,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 UNPUB UNPUB 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-05 2020-11-16 2021-03-30
Assets 10,368,000 39,316,000 34,070,000 31,417,000
Current Assets 10,123,000 38,899,000 34,070,000 31,417,000
Current Liabilities 1,907,000 3,190,000 2,885,000 2,347,000
Equity 8,461,000 36,126,000 31,185,000 29,070,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 8,461,000 36,126,000 31,185,000 29,070,000
Liabilities -8,461,000 -36,126,000 2,885,000 2,347,000
Liabilities And Equity 10,368,000 39,316,000 34,070,000 31,417,000
Noncurrent Assets 245,000 417,000 0 0
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-05 2020-11-16 2021-03-30
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -3,749,000 0 0 0
Net Cash Flow, Continuing -3,749,000 0 0 0
Net Cash Flow From Financing Activities 0 31,944,000 -117,000 32,289,000
Net Cash Flow From Financing Activities, Continuing 0 31,944,000 -117,000 32,289,000
Net Cash Flow From Investing Activities 3,749,000 -28,828,000 5,563,000 -16,694,000
Net Cash Flow From Investing Activities, Continuing 3,749,000 -28,828,000 5,563,000 -16,694,000
Net Cash Flow From Operating Activities -3,749,000 -3,116,000 -5,446,000 -15,595,000
Net Cash Flow From Operating Activities, Continuing -3,749,000 -3,116,000 -5,446,000 -15,595,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-05 2020-11-16 2021-03-30
Comprehensive Income/Loss -3,826,000 -4,845,000 -6,200,000 -18,109,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,826,000 -4,845,000 -6,200,000 -18,109,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-05 2020-11-16 2021-03-30
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 18,279,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 18,055,000
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,826,000 -4,845,000 -6,200,000 -18,109,000
Income/Loss From Continuing Operations Before Tax -3,826,000 -4,845,000 -6,200,000 -18,109,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,826,000 -4,845,000 -6,200,000 -18,109,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,826,000 -4,845,000 -6,200,000 -18,109,000
Net Income/Loss Available To Common Stockholders, Basic -3,826,000 -4,845,000 -6,200,000 -18,109,000
Operating Expenses UNPUB UNPUB UNPUB 18,055,000
Operating Income/Loss -3,835,000 -4,845,000 -5,859,000 -17,885,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 170,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-09 2019-11-12 2020-02-14
Assets 20,657,000 17,829,000 15,907,000 14,146,000
Current Assets 20,343,000 17,532,000 15,627,000 13,884,000
Current Liabilities 1,451,000 1,353,000 905,000 2,271,000
Equity 19,206,000 16,476,000 15,002,000 11,875,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 19,206,000 16,476,000 15,002,000 11,875,000
Liabilities -19,206,000 -16,476,000 905,000 2,271,000
Liabilities And Equity 20,657,000 17,829,000 15,907,000 14,146,000
Noncurrent Assets 314,000 297,000 280,000 262,000
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-09 2019-11-12 2020-02-14
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -2,550,000 -2,756,000 -2,235,000 0
Net Cash Flow, Continuing -2,550,000 -2,756,000 -2,235,000 0
Net Cash Flow From Financing Activities -71,000 0 0 -71,000
Net Cash Flow From Financing Activities, Continuing -71,000 0 0 -71,000
Net Cash Flow From Investing Activities UNPUB UNPUB 2,235,000 9,131,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB 2,235,000 9,131,000
Net Cash Flow From Operating Activities -2,479,000 -2,756,000 -2,235,000 -9,060,000
Net Cash Flow From Operating Activities, Continuing -2,479,000 -2,756,000 -2,235,000 -9,060,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-09 2019-11-12 2020-02-14
Comprehensive Income/Loss -2,626,000 -4,730,000 -1,809,000 -12,775,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,626,000 -4,730,000 -1,809,000 -12,775,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-09 2019-11-12 2020-02-14
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,626,000 -4,730,000 -1,809,000 -12,775,000
Income/Loss From Continuing Operations Before Tax -2,626,000 -4,730,000 -1,809,000 -12,775,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -2,626,000 -4,730,000 -1,809,000 -12,775,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,626,000 -4,730,000 -1,809,000 -12,775,000
Net Income/Loss Available To Common Stockholders, Basic -2,626,000 -4,730,000 -1,809,000 -12,775,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -2,680,000 -4,813,000 -1,863,000 -13,009,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-13 2018-11-13 2019-03-15
Assets 26,836,000 25,704,000 24,935,000 22,950,000
Current Assets 26,836,000 25,704,000 24,935,000 22,950,000
Current Liabilities 1,173,000 847,000 2,076,000 1,637,000
Equity 25,663,000 24,857,000 22,859,000 21,313,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 25,663,000 24,857,000 22,859,000 21,313,000
Liabilities 1,173,000 847,000 2,076,000 1,637,000
Liabilities And Equity 26,836,000 25,704,000 24,935,000 22,950,000
Noncurrent Assets 0 0 0 0
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-13 2018-11-13 2019-03-15
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -1,541,000 -1,079,000 -1,116,000 -5,479,000
Net Cash Flow, Continuing -1,541,000 -1,079,000 -1,116,000 -5,479,000
Net Cash Flow From Financing Activities 186,000 491,000 483,000 2,347,000
Net Cash Flow From Financing Activities, Continuing 186,000 491,000 483,000 2,347,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB 0
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB UNPUB
Net Cash Flow From Operating Activities -1,727,000 -1,570,000 -1,599,000 -7,826,000
Net Cash Flow From Operating Activities, Continuing -1,727,000 -1,570,000 -1,599,000 -7,826,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-13 2018-11-13 2019-03-15
Comprehensive Income/Loss -1,568,000 -2,587,000 -2,749,000 -9,888,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,568,000 -2,587,000 -2,749,000 -9,888,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-13 2018-11-13 2019-03-15
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -1,568,000 -2,587,000 -2,749,000 -9,888,000
Income/Loss From Continuing Operations Before Tax -1,568,000 -2,587,000 -2,749,000 -9,888,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -1,568,000 -2,587,000 -2,749,000 -9,888,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,568,000 -2,587,000 -2,749,000 -9,888,000
Net Income/Loss Available To Common Stockholders, Basic -1,568,000 -2,587,000 -2,749,000 -9,888,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -1,791,000 -2,665,000 -2,848,000 -10,409,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2017-11-13 2018-03-28
Assets UNPUB UNPUB 9,888,000 28,401,000
Current Assets UNPUB UNPUB 9,888,000 28,401,000
Current Liabilities UNPUB UNPUB 1,030,000 1,644,000
Equity UNPUB UNPUB 8,858,000 26,757,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Equity Attributable To Parent UNPUB UNPUB 8,858,000 26,757,000
Liabilities UNPUB UNPUB 1,030,000 1,644,000
Liabilities And Equity UNPUB UNPUB 9,888,000 28,401,000
Noncurrent Assets UNPUB UNPUB 0 0
Noncurrent Liabilities UNPUB UNPUB 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2017-11-13 2018-03-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB -544,000 24,334,000
Net Cash Flow, Continuing UNPUB UNPUB -544,000 24,334,000
Net Cash Flow From Financing Activities UNPUB UNPUB 414,000 27,975,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 414,000 27,975,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB 0
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB UNPUB
Net Cash Flow From Operating Activities UNPUB UNPUB -958,000 -3,641,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -958,000 -3,641,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2017-11-13 2018-03-28
Comprehensive Income/Loss UNPUB UNPUB -2,352,000 -7,046,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB -2,352,000 -7,046,000
Other Comprehensive Income/Loss UNPUB UNPUB 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2017-11-13 2018-03-28
Basic Earnings Per Share UNPUB UNPUB 0 UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB -2,352,000 -7,046,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB -2,352,000 -7,046,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB UNPUB -2,352,000 -7,046,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Net Income/Loss Attributable To Parent UNPUB UNPUB -2,352,000 -7,046,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB -2,352,000 -7,046,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss UNPUB UNPUB -2,186,000 -6,951,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB 0 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB 0 0
Revenues UNPUB UNPUB 0 0
Calendar
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:FENC240517C00020000 OCASPS Call American 100 20 BATO 2024-05-17
O:FENC240517C00017500 OCASPS Call American 100 17.5 BATO 2024-05-17
O:FENC240517P00015000 OPASPS Put American 100 15 BATO 2024-05-17
O:FENC240517P00012500 OPASPS Put American 100 12.5 BATO 2024-05-17
O:FENC240517P00010000 OPASPS Put American 100 10 BATO 2024-05-17
O:FENC240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:FENC240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:FENC240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:FENC240517C00015000 OCASPS Call American 100 15 BATO 2024-05-17
O:FENC240517C00012500 OCASPS Call American 100 12.5 BATO 2024-05-17
O:FENC240517C00010000 OCASPS Call American 100 10 BATO 2024-05-17
O:FENC240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:FENC240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:FENC240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:FENC240517P00020000 OPASPS Put American 100 20 BATO 2024-05-17
O:FENC240517P00017500 OPASPS Put American 100 17.5 BATO 2024-05-17
O:FENC240419C00020000 OCASPS Call American 100 20 BATO 2024-04-19
O:FENC240419C00017500 OCASPS Call American 100 17.5 BATO 2024-04-19
O:FENC240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:FENC240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:FENC240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:FENC240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:FENC240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:FENC240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:FENC240419P00020000 OPASPS Put American 100 20 BATO 2024-04-19
O:FENC240419P00017500 OPASPS Put American 100 17.5 BATO 2024-04-19
O:FENC240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:FENC240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:FENC240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:FENC240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:FENC240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:FENC240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:FENC240315P00020000 OPASPS Put American 100 20 BATO 2024-03-15
O:FENC240315P00017500 OPASPS Put American 100 17.5 BATO 2024-03-15
O:FENC240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:FENC240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:FENC240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:FENC240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:FENC240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:FENC240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:FENC240315C00020000 OCASPS Call American 100 20 BATO 2024-03-15
O:FENC240315C00017500 OCASPS Call American 100 17.5 BATO 2024-03-15
O:FENC240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:FENC240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:FENC240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:FENC240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:FENC240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:FENC240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:FENC240216P00017500 OPASPS Put American 100 17.5 BATO 2024-02-16
O:FENC240216P00015000 OPASPS Put American 100 15 BATO 2024-02-16
O:FENC240216P00012500 OPASPS Put American 100 12.5 BATO 2024-02-16
O:FENC240216P00010000 OPASPS Put American 100 10 BATO 2024-02-16
O:FENC240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:FENC240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:FENC240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:FENC240216C00017500 OCASPS Call American 100 17.5 BATO 2024-02-16
O:FENC240216C00015000 OCASPS Call American 100 15 BATO 2024-02-16
O:FENC240216C00012500 OCASPS Call American 100 12.5 BATO 2024-02-16
O:FENC240216C00010000 OCASPS Call American 100 10 BATO 2024-02-16
O:FENC240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:FENC240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:FENC240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:FENC240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:FENC240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:FENC240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:FENC240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:FENC240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:FENC240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:FENC240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:FENC240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:FENC240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:FENC240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:FENC240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:FENC240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:FENC231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:FENC231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:FENC231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:FENC231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:FENC231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:FENC231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:FENC231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:FENC231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:FENC231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:FENC231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:FENC231117P00017500 OPASPS Put American 100 17.5 BATO 2023-11-17
O:FENC231117P00015000 OPASPS Put American 100 15 BATO 2023-11-17
O:FENC231117P00012500 OPASPS Put American 100 12.5 BATO 2023-11-17
O:FENC231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:FENC231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:FENC231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:FENC231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:FENC231117C00017500 OCASPS Call American 100 17.5 BATO 2023-11-17
O:FENC231117C00015000 OCASPS Call American 100 15 BATO 2023-11-17
O:FENC231117C00012500 OCASPS Call American 100 12.5 BATO 2023-11-17
O:FENC231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:FENC231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:FENC231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:FENC231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:FENC231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:FENC231020P00012500 OPASPS Put American 100 12.5 BATO 2023-10-20
O:FENC231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:FENC231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:FENC231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:FENC231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:FENC231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:FENC231020C00012500 OCASPS Call American 100 12.5 BATO 2023-10-20
O:FENC231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:FENC231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:FENC231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:FENC231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:FENC230915P00017500 OPASPS Put American 100 17.5 BATO 2023-09-15
O:FENC230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:FENC230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:FENC230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:FENC230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:FENC230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:FENC230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:FENC230915C00017500 OCASPS Call American 100 17.5 BATO 2023-09-15
O:FENC230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:FENC230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:FENC230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:FENC230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:FENC230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:FENC230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:FENC230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:FENC230818P00017500 OPASPS Put American 100 17.5 BATO 2023-08-18
O:FENC230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:FENC230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:FENC230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:FENC230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:FENC230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:FENC230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:FENC230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
O:FENC230818C00017500 OCASPS Call American 100 17.5 BATO 2023-08-18
O:FENC230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:FENC230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
O:FENC230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:FENC230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:FENC230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:FENC230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Calendar Calendar of Events
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024. Management will host a conference call and webcast that day to discuss the Company’s financial and business results.
GlobeNewswire Inc. • 1w ago
News News
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Tops Revenue Estimates
Adherex Technologies (FENC) delivered earnings and revenue surprises of -600% and 2.80%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 1mo ago
Stocks Earnings Releases and Operating Results
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
~ Achieved PEDMARK® Full-Year 2023 Net Product Sales of $21.3 Million, Including $9.7 Million in Net Product Sales in the Fourth Quarter of 2023 ~
GlobeNewswire Inc. • 1mo ago
News News
Adherex Technologies Inc. (FENC) is on the Move, Here's Why the Trend Could be Sustainable
Adherex Technologies Inc. (FENC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Zacks Investment Research • 2mo ago
Calendar Calendar of Events
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
RESEARCH TRIANGLE PARK, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its full year and fourth quarter 2023 financial results before the opening of the U.S. financial markets on Thursday, March 21, 2024. Management will host a conference call and webcast that day to discuss the Company’s financial and business results.
GlobeNewswire Inc. • 2mo ago
Stocks Licensing Agreements
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI®, the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with localized, non-metastatic solid tumors
GlobeNewswire Inc. • 2mo ago
News News
Wall Street Analysts See a 64.61% Upside in Adherex Technologies Inc. (FENC): Can the Stock Really Move This High?
The consensus price target hints at a 64.6% upside potential for Adherex Technologies Inc. (FENC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks Investment Research • 2mo ago
News Pre-Release Comments
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
~ Fourth Quarter 2023 Net Revenues of Approximately $9.2 to $9.7 Million ~
GlobeNewswire Inc. • 2mo ago
Health Health
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a public reminder to healthcare providers that PEDMARK (sodium thiosulfate injection) is not substitutable with other sodium thiosulfate products as explicitly directed in its prescribing label. PEDMARK is the first and only FDA approved therapy indicated to reduce the risk of ototoxicity (e.g., permanent hearing loss) associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors.
GlobeNewswire Inc. • 3mo ago
News News
Recent Price Trend in Adherex Technologies Inc. (FENC) is Your Friend, Here's Why
Adherex Technologies Inc. (FENC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Zacks Investment Research • 5mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT